By combining computational and experimental validations, we confirmed that at least DDIT4, FOXO1, and STAT3 were significantly upregulated in both osteoporosis and sarcopenia, providing strong support for precise disease diagnosis, further exploration of comorbidity mechanisms, and potential therapeutic interventions. This evidence concerns the gene FOXO1 and sarcopenia.